Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Lawrie TA, Rabbie R, Thoma C, et al. Pegylated liposomal doxorubicin for first-line treatment of epithelial ovarian cancer. Cochrane Database Syst Rev. 2013;10:CD010482.
   Google Scholar
• Pérez-Herrero E, Fernández-Medarde A. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm. 2015;93:52–79.
   PubMed Web of Science ®Google Scholar
• Sun M, Yang C, Zheng J, et al. Enhanced efficacy of chemotherapy for breast cancer stem cells by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense. Acta Biomater. 2015;28:171–182.
   PubMed Web of Science ®Google Scholar
• Seib FP, Pritchard EM, Kaplan DL. Self-assembling doxorubicin silk hydrogels for the focal treatment of primary breast cancer. Adv Funct Mater. 2013;23:58–65.
   PubMed Web of Science ®Google Scholar
• Lin C-J, Kuan C-H, Wang L-W, et al. Integrated self-assembling drug delivery system possessing dual responsive and active targeting for orthotopic ovarian cancer theranostics. Biomaterials. 2016;90:12–26.
   PubMed Web of Science ®Google Scholar
• Hunault-Berger M, Leguay T, Thomas X, et al. A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study. Haematologica. 2011;96:245–252.
   PubMed Web of Science ®Google Scholar
• Ma P, Mumper RJ. Anthracycline nano-delivery systems to overcome multiple drug resistance: a comprehensive review. Nano Today. 2013;8:313–331.
   PubMed Web of Science ®Google Scholar
• Aller SG, Yu J, Ward A, et al. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science. 2009;323:1718–1722.
   PubMed Web of Science ®Google Scholar
• Robey RW, Pluchino KM, Hall MD, et al. Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer. 2018;18:452–464.
   PubMed Web of Science ®Google Scholar
• Yang H, Wang N, Mo L, et al. Reduction sensitive hyaluronan-SS-poly(ε-caprolactone) block copolymers as theranostic nanocarriers for tumor diagnosis and treatment. Mater Sci Eng C. 2019;98:9–18.
   PubMed Web of Science ®Google Scholar
• Tian Y, Zhang H, Qin Y, et al. Overcoming drug-resistant lung cancer by paclitaxel-loaded hyaluronic acid-coated liposomes targeted to mitochondria. Drug Dev Ind Pharm. 2018;44:2071–2082.
   PubMed Web of Science ®Google Scholar
• Silva R, Vilas-Boas V, Carmo H, et al. Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy. Pharmacol Ther. 2015;149:1–123.
   PubMed Web of Science ®Google Scholar
• Busija DW, Rutkai I, Dutta S, et al. Role of mitochondria in cerebral vascular function: energy production, cellular protection, and regulation of vascular tone. Compr Physiol. 2016;6:1529–1548.
   PubMed Web of Science ®Google Scholar
• Han K, Zhu J-Y, Jia H-Z, et al. Mitochondria-targeted chimeric peptide for trinitarian overcoming of drug resistance. ACS Appl Mater Interfaces. 2016;8:25060–25068.
   PubMed Web of Science ®Google Scholar
• Bhola PD, Letai A. Mitochondria-judges and executioners of cell death sentences. Mol Cell. 2016;61:695–704.
   PubMed Web of Science ®Google Scholar
• van Gisbergen MW, Voets AM, Starmans MHW, et al. How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models. Mutat Res Rev Mutat Res. 2015;764:16–30.
   PubMed Web of Science ®Google Scholar
• Pan Y, Cao M, Liu J, et al. Metabolic regulation in mitochondria and drug resistance. Adv Exp Med Biol. 2017;1038:149–171.
   PubMedGoogle Scholar
• Chen Z-P, Li M, Zhang L-J, et al. Mitochondria-targeted drug delivery system for cancer treatment. J Drug Target. 2016;24:492–502.
   PubMed Web of Science ®Google Scholar
• Chan MS, Liu LS, Leung HM, et al. Cancer-cell-specific mitochondria-targeted drug delivery by dual-ligand-functionalized nanodiamonds circumvent drug resistance. ACS Appl Mater Interfaces. 2017;9:11780–11789.
   PubMed Web of Science ®Google Scholar
• Zielonka J, Joseph J, Sikora A, et al. Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications. Chem Rev. 2017;117:10043–10120.
   PubMed Web of Science ®Google Scholar
• Momekova D, Ugrinova I, Slavkova M, et al. Superior proapoptotic activity of curcumin-loaded mixed block copolymer micelles with mitochondrial targeting properties. Biomater Sci. 2018;6:3309–3317.
   PubMed Web of Science ®Google Scholar
• Han M, Vakili MR, Soleymani Abyaneh H, et al. Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells. Mol Pharm. 2014;11:2640–2649.
   PubMed Web of Science ®Google Scholar
• Liu H-N, Guo N-N, Wang T-T, et al. Mitochondrial targeted doxorubicin-triphenylphosphonium delivered by hyaluronic acid modified and pH responsive nanocarriers to breast tumor: in vitro and in vivo studies. Mol Pharm. 2018;15:882–891.
   PubMed Web of Science ®Google Scholar
• Gao S, Tang G, Hua D, et al. Stimuli-responsive bio-based polymeric systems and their applications. J Mater Chem B. 2019;7:709–729.
   PubMed Web of Science ®Google Scholar
• Li Z, Chen Q, Qi Y, et al. Rational design of multifunctional polymeric nanoparticles based on poly (L-histidine) and d-α-vitamin E succinate for reversing tumor multidrug resistance. Biomacromolecules. 2018;19:2595–2609.
   PubMed Web of Science ®Google Scholar
• Wang L-L, He D-D, Wang S-X, et al. Preparation and evaluation of curcumin-loaded self-assembled micelles. Drug Dev Ind Pharm. 2018;44:563–569.
   PubMed Web of Science ®Google Scholar
• Han Y, Yin W, Li J, et al. Intracellular glutathione-depleting polymeric micelles for cisplatin prodrug delivery to overcome cisplatin resistance of cancers. J Control Release. 2018;273:30–39.
   PubMed Web of Science ®Google Scholar
• Sim T, Kim JE, Hoang NH, et al. Development of a docetaxel micellar formulation using poly(ethylene glycol)-polylactide-poly(ethylene glycol) (PEG-PLA-PEG) with successful reconstitution for tumor targeted drug delivery. Drug Deliv. 2018;25:1362–1371.
   PubMed Web of Science ®Google Scholar
• Yin T, Wang Y, Chu X, et al. Free adriamycin-loaded pH/reduction dual-responsive hyaluronic acid-adriamycin prodrug micelles for efficient cancer therapy. ACS Appl Mater Interfaces. 2018;10:35693–35704.
   PubMed Web of Science ®Google Scholar
• Heredia V, Alasino RV, Leonhard V, et al. Sialoganglioside micelles for enhanced paclitaxel solubility: in vitro characterization. J Pharm Sci. 2016;105:268–275.
   PubMed Web of Science ®Google Scholar
• Ye L, Zhang Y, Yang B, et al. Zwitterionic-modified starch-based stealth micelles for prolonging circulation time and reducing macrophage response. ACS Appl Mater Interfaces. 2016;8:4385–4398.
   PubMed Web of Science ®Google Scholar
• Wang N, He T, Shen Y, et al. Paclitaxel and tacrolimus coencapsulated polymeric micelles that enhance the therapeutic effect of drug-resistant ovarian cancer. ACS Appl Mater Interfaces. 2016;8:4368–4377.
   PubMed Web of Science ®Google Scholar
• Yang Y, Yuan S-X, Zhao L-H, et al. Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer. Mol Pharm. 2015;12:644–652.
   PubMedGoogle Scholar
• Li W, Li W, Kuang Y, et al. Toxicity assessment of PEG-PCCL nanoparticles and preliminary investigation on its anti-tumor effect of paclitaxel-loading. Nanoscale Res Lett. 2018;13:253.
   PubMed Web of Science ®Google Scholar
• Li X, Yang Y, Jia Y, et al. Enhanced tumor targeting effects of a novel paclitaxel-loaded polymer: PEG-PCCL-modified magnetic iron oxide nanoparticles. Drug Deliv. 2017;24:1284–1294.
   PubMed Web of Science ®Google Scholar
• Mahmud A, Xiong X-B, Lavasanifar A. Novel self-associating poly(ethylene oxide)-block-poly(ε-caprolactone) block copolymers with functional side groups on the polyester block for drug delivery. Macromolecules. 2006;39:9419–9428.
   Web of Science ®Google Scholar
• Kang XJ, Wang HY, Peng HG, et al. Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy. Acta Pharmacol Sin. 2017;38:885–896.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhao Y, Wang H, et al. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer. J Control Release 2014;192:47–56.
   PubMed Web of Science ®Google Scholar
• Guo Q, Wang H, Zhao Y, et al. Cell-penetrating albumin conjugates for enhanced doxorubicin delivery. Polym Chem. 2013;4:4584–4587.
   Web of Science ®Google Scholar
• Danhier F, Danhier P, De Saedeleer CJ, et al. Paclitaxel-loaded micelles enhance transvascular permeability and retention of nanomedicines in tumors. Int J Pharm. 2015;479:399–407.
   PubMed Web of Science ®Google Scholar
• Ocal H, Arica-Yegin B, Vural I, et al. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies. Drug Dev Ind Pharm. 2014;40:560–567.
   PubMed Web of Science ®Google Scholar
• Yoncheva K, Kamenova K, Perperieva T, et al. Cationic triblock copolymer micelles enhance antioxidant activity, intracellular uptake and cytotoxicity of curcumin. Int J Pharm. 2015;490:298–307.
   PubMed Web of Science ®Google Scholar
• Chen L, Zang F, Wu H, et al. Using PEGylated magnetic nanoparticles to describe the EPR effect in tumor for predicting therapeutic efficacy of micelle drugs. Nanoscale. 2018;10:1788–1797.
   PubMed Web of Science ®Google Scholar